These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16181092)

  • 1. From brain ischemia-reperfusion injury to possible sporadic Alzheimer's disease.
    Pluta R
    Curr Neurovasc Res; 2004 Dec; 1(5):441-53. PubMed ID: 16181092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer lesions after ischemia-reperfusion brain injury.
    Pluta R
    Folia Neuropathol; 2004; 42(3):181-6. PubMed ID: 15535038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes.
    Pluta R; Jabłoński M; Ułamek-Kozioł M; Kocki J; Brzozowska J; Januszewski S; Furmaga-Jabłońska W; Bogucka-Kocka A; Maciejewski R; Czuczwar SJ
    Mol Neurobiol; 2013 Dec; 48(3):500-15. PubMed ID: 23519520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Alzheimer's disease risk genes in ischemic brain degeneration.
    Ułamek-Kozioł M; Pluta R; Januszewski S; Kocki J; Bogucka-Kocka A; Czuczwar SJ
    Pharmacol Rep; 2016 Dec; 68(6):1345-1349. PubMed ID: 27710863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered?
    Savory J; Exley C; Forbes WF; Huang Y; Joshi JG; Kruck T; McLachlan DR; Wakayama I
    J Toxicol Environ Health; 1996 Aug; 48(6):615-35. PubMed ID: 8772802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alzheimer dementia: more than amyloid plaques and neurofibrillary degeneration].
    Bauer J
    Fortschr Med; 1994 Mar; 112(7):81-4. PubMed ID: 8175096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuropathologic investigation in autopsies with special emphasis on findings in Alzheimer's disease].
    Leel-Ossy L; Kindler M; Szucs I; Schwarcz T
    Ideggyogy Sz; 2006 May; 59(5-6):164-77. PubMed ID: 16786711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are vascular factors involved in Alzheimer's disease? Facts and theories.
    Di Iorio A; Zito M; Lupinetti M; Abate G
    Aging (Milano); 1999 Dec; 11(6):345-52. PubMed ID: 10738848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Many Faces of Post-Ischemic Tau Protein in Brain Neurodegeneration of the Alzheimer's Disease Type.
    Pluta R; Czuczwar SJ; Januszewski S; Jabłoński M
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postischemic dementia with Alzheimer phenotype: selectively vulnerable versus resistant areas of the brain and neurodegeneration versus β-amyloid peptide.
    Pluta R; Jabłoński M; Czuczwar SJ
    Folia Neuropathol; 2012; 50(2):101-9. PubMed ID: 22773455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the ischemic blood-brain barrier insufficiency responsible for full-blown Alzheimer's disease?
    Pluta R
    Neurol Res; 2006 Sep; 28(6):665-71. PubMed ID: 16945220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The search for diagnostic criteria in Alzheimer's disease: an update.
    Prayson RA; Estes ML
    Cleve Clin J Med; 1994; 61(2):115-22; quiz 162. PubMed ID: 8194175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etiology and pathogenesis of Alzheimer dementia].
    Kratzsch T; Peters J; Frölich L
    Wien Med Wochenschr; 2002; 152(3-4):72-6. PubMed ID: 11925775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropathologic, immunologic and psychobiological aspects of Alzheimer's dementia].
    Bauer J; Berger M
    Fortschr Neurol Psychiatr; 1993 Jul; 61(7):225-40. PubMed ID: 8365703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reimagining Alzheimer's disease--an age-based hypothesis.
    Herrup K
    J Neurosci; 2010 Dec; 30(50):16755-62. PubMed ID: 21159946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrovascular damage as a cause for Alzheimer's disease.
    Humpel C; Marksteiner J
    Curr Neurovasc Res; 2005 Oct; 2(4):341-7. PubMed ID: 16181125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alzheimer's disease, amyloidosis, microglia and astrocytes].
    Hauw JJ; Duyckaerts C; Delaere P; Chaunu MP
    Rev Neurol (Paris); 1988; 144(3):155-7. PubMed ID: 3285438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of chronic brain hypoperfusion in the pathogenesis of Alzheimer's disease--facts and hypotheses].
    Zádori D; Datki Z; Penke B
    Ideggyogy Sz; 2007 Nov; 60(11-12):428-37. PubMed ID: 18198789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis.
    de la Torre JC
    Neurobiol Aging; 2000; 21(2):331-42. PubMed ID: 10867218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular factors in Alzheimer's disease.
    Kalaria RN
    Int Psychogeriatr; 2003; 15 Suppl 1():47-52. PubMed ID: 16191216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.